| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 1758 | 2018 |
| Induction of CD8+ T-cell responses against novel glioma–associated antigen peptides and clinical activity by vaccinations with α-type 1 polarized dendritic cells and … H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ... Journal of clinical oncology 29 (3), 330, 2011 | 616 | 2011 |
| Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment S Müller, G Kohanbash, SJ Liu, B Alvarado, D Carrera, A Bhaduri, ... Genome biology 18, 1-14, 2017 | 434 | 2017 |
| COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor CellsCOX-2 Blockade and Gliomagenesis M Fujita, G Kohanbash, W Fellows-Mayle, RL Hamilton, Y Komohara, ... Cancer research 71 (7), 2664-2674, 2011 | 385 | 2011 |
| Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas G Kohanbash, DA Carrera, S Shrivastav, BJ Ahn, N Jahan, T Mazor, ... The Journal of clinical investigation 127 (4), 1425-1437, 2017 | 290 | 2017 |
| Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1 R Ueda, G Kohanbash, K Sasaki, M Fujita, X Zhu, ER Kastenhuber, ... Proceedings of the National Academy of Sciences 106 (26), 10746-10751, 2009 | 195 | 2009 |
| Immunotherapeutic approaches for glioma H Okada, G Kohanbash, X Zhu, ER Kastenhuber, A Hoji, R Ueda, M Fujita Critical Reviews™ in Immunology 29 (1), 2009 | 190 | 2009 |
| GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-αIL-4Rα+ Suppressive Myeloid Cells in Gliomas G Kohanbash, K McKaveney, M Sakaki, R Ueda, AH Mintz, N Amankulor, ... Cancer research 73 (21), 6413-6423, 2013 | 183 | 2013 |
| The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of VariationA Draft Single-cell Atlas of Human Glioma L Wang, H Babikir, S Müller, G Yagnik, K Shamardani, F Catalan, ... Cancer discovery 9 (12), 1708-1719, 2019 | 179 | 2019 |
| Novel and shared neoantigen derived from histone 3 variant H3. 3K27M mutation for glioma T cell therapy ZS Chheda, G Kohanbash, K Okada, N Jahan, J Sidney, M Pecoraro, ... Journal of Experimental Medicine 215 (1), 141-157, 2018 | 176 | 2018 |
| MicroRNAs in immune regulation—opportunities for cancer immunotherapy H Okada, G Kohanbash, MT Lotze The international journal of biochemistry & cell biology 42 (8), 1256-1261, 2010 | 134 | 2010 |
| Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide VaccinesTGF-β Blockade … R Ueda, M Fujita, X Zhu, K Sasaki, ER Kastenhuber, G Kohanbash, ... Clinical Cancer Research 15 (21), 6551-6559, 2009 | 134 | 2009 |
| IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression X Zhang, A Rao, P Sette, C Deibert, A Pomerantz, WJ Kim, G Kohanbash, ... Neuro-oncology 18 (10), 1402-1412, 2016 | 121 | 2016 |
| MicroRNAs and STAT interplay G Kohanbash, H Okada Seminars in cancer biology 22 (1), 70-75, 2012 | 113 | 2012 |
| Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells—significant roles of CXCL10 M Fujita, X Zhu, R Ueda, K Sasaki, G Kohanbash, ER Kastenhuber, ... Cancer research 69 (4), 1587-1595, 2009 | 113 | 2009 |
| Single‐cell sequencing maps gene expression to mutational phylogenies in PDGF‐and EGF‐driven gliomas S Müller, SJ Liu, E Di Lullo, M Malatesta, AA Pollen, TJ Nowakowski, ... Molecular systems biology 12 (11), 889, 2016 | 99 | 2016 |
| Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas H Okada, KL Low, G Kohanbash, HA McDonald, RL Hamilton, IF Pollack Journal of neuro-oncology 88, 245-250, 2008 | 99 | 2008 |
| Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC H Okada, LH Butterfield, RL Hamilton, A Hoji, M Sakaki, BJ Ahn, ... Clinical cancer research 21 (2), 286-294, 2015 | 97 | 2015 |
| Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners X Zhu, BA Fallert-Junecko, M Fujita, R Ueda, G Kohanbash, ... Cancer Immunology, Immunotherapy 59, 1401-1409, 2010 | 96 | 2010 |
| Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma SJ Han, G Reis, G Kohanbash, S Shrivastav, ST Magill, AM Molinaro, ... Journal of neuro-oncology 130, 543-552, 2016 | 95 | 2016 |
